Fed. Circ. Wrong On HIV Drug Patent Challenge, Justices Hear
A health care group told the U.S. Supreme Court it was improperly barred by the Federal Circuit from challenging a patent for an HIV drug because it had not filed an...To view the full article, register now.
Already a subscriber? Click here to view full article